12:09 PM EST - Response Biomedical Corporation : announced that it has entered into an exclusive distribution agreement with Cremascoli & Iris, s.r.l. of Milan, Italy to distribute the full line of RAMP(R) cardiac products in Italy, the second-largest market in Europe after Germany for cardiac Point of Care Testing (POCT). Response Biomedical Corporation
shares T.RBM are trading even at $0.35.
